{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:22:11Z","timestamp":1790835731555,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are no approved therapies for Ebola virus infection. Here, to find potential therapeutic targets, we perform a screen for genes essential for Ebola virus (EBOV) infection. We identify <jats:italic>GNPTAB<\/jats:italic>, which encodes the \u03b1 and \u03b2 subunits of N-acetylglucosamine-1-phosphate transferase. We show that EBOV infection of a <jats:italic>GNPTAB<\/jats:italic> knockout cell line is impaired, and that this is reversed by reconstituting GNPTAB expression. Fibroblasts from patients with mucolipidosis II, a disorder associated with mutations in <jats:italic>GNPTAB<\/jats:italic>, are refractory to EBOV, whereas cells from their healthy parents support infection. Impaired infection correlates with loss of the expression of cathepsin B, known to be essential for EBOV entry. GNPTAB activity is dependent upon proteolytic cleavage by the SKI-1\/S1P protease. Inhibiting this protease with the small-molecule PF-429242 blocks EBOV entry and infection. Disruption of GNPTAB function may represent a strategy for a host-targeted therapy for EBOV.<\/jats:p>","DOI":"10.1038\/s41467-018-08135-4","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T15:07:19Z","timestamp":1547219239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5373-787X","authenticated-orcid":false,"given":"Mike","family":"Flint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payel","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2748-5151","authenticated-orcid":false,"given":"Laura K.","family":"McMullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punya","family":"Shrivastava-Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-8628","authenticated-orcid":false,"given":"\u00c9ric","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-7896","authenticated-orcid":false,"given":"Michael K.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-450X","authenticated-orcid":false,"given":"Andrew W.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"8135_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","volume":"377","author":"H Feldmann","year":"2011","unstructured":"Feldmann, H. & Geisbert, T. W. Ebola haemorrhagic fever. Lancet 377, 849\u2013862 (2011).","journal-title":"Lancet"},{"key":"8135_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet 389, 505\u2013518 (2017).","journal-title":"Lancet"},{"key":"8135_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 (2016).","journal-title":"Nature"},{"key":"8135_CR4","doi-asserted-by":"crossref","unstructured":"Pascal, K. E., et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J. Infect. Dis. 218, S612\u2013S626 (2018).","DOI":"10.1093\/infdis\/jiy285"},{"key":"8135_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","volume":"508","author":"TK Warren","year":"2014","unstructured":"Warren, T. K. et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 508, 402\u2013405 (2014).","journal-title":"Nature"},{"key":"8135_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","volume":"151","author":"SL Bixler","year":"2018","unstructured":"Bixler, S. L. et al. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antivir. Res. 151, 97\u2013104 (2018).","journal-title":"Antivir. Res."},{"key":"8135_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tim.2015.04.006","volume":"23","author":"LT Jae","year":"2015","unstructured":"Jae, L. T. & Brummelkamp, T. R. Emerging intracellular receptors for hemorrhagic fever viruses. Trends Microbiol. 23, 392\u2013400 (2015).","journal-title":"Trends Microbiol."},{"key":"8135_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coviro.2012.02.015","volume":"2","author":"EH Miller","year":"2012","unstructured":"Miller, E. H. & Chandran, K. Filovirus entry into cells - new insights. Curr. Opin. Virol. 2, 206\u2013214 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"8135_CR9","doi-asserted-by":"publisher","first-page":"e1004731","DOI":"10.1371\/journal.ppat.1004731","volume":"11","author":"S Moller-Tank","year":"2015","unstructured":"Moller-Tank, S. & Maury, W. Ebola virus entry: a curious and complex series of events. PLoS. Pathog. 11, e1004731 (2015).","journal-title":"PLoS. Pathog."},{"key":"8135_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2764","volume":"10","author":"JM White","year":"2012","unstructured":"White, J. M. & Schornberg, K. L. A new player in the puzzle of filovirus entry. Nat. Rev. Microbiol. 10, 317\u2013322 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"8135_CR11","first-page":"323","volume":"411","author":"RA Davey","year":"2017","unstructured":"Davey, R. A. et al. Mechanisms of filovirus entry. Curr. Top. Microbiol. Immunol. 411, 323\u2013352 (2017).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"8135_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340\u2013343 (2011).","journal-title":"Nature"},{"key":"8135_CR13","doi-asserted-by":"publisher","first-page":"e00565","DOI":"10.1128\/mBio.00565-15","volume":"6","author":"AS Herbert","year":"2015","unstructured":"Herbert, A. S. et al. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. mBio 6, e00565\u201300515 (2015).","journal-title":"mBio"},{"key":"8135_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature10380","volume":"477","author":"M Cote","year":"2011","unstructured":"C\u00f4t\u00e9, M. et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344\u2013348 (2011).","journal-title":"Nature"},{"key":"8135_CR15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643\u20131645 (2005).","journal-title":"Science"},{"key":"8135_CR16","doi-asserted-by":"publisher","first-page":"e0005540","DOI":"10.1371\/journal.pntd.0005540","volume":"11","author":"EA Nelson","year":"2017","unstructured":"Nelson, E. A. et al. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. PLoS Negl. Trop. Dis. 11, e0005540 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"8135_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12985-015-0420-3","volume":"12","author":"H Cheng","year":"2015","unstructured":"Cheng, H. et al. A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus. Virol. J. 12, 194 (2015).","journal-title":"Virol. J."},{"key":"8135_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/adt.2014.613","volume":"13","author":"CM Filone","year":"2015","unstructured":"Filone, C. M., Dower, K., Cowley, G. S., Hensley, L. E. & Connor, J. H. Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA. Assay. Drug Dev. Technol. 13, 34\u201343 (2015).","journal-title":"Assay. Drug Dev. Technol."},{"key":"8135_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0570-1","volume":"10","author":"S Martin","year":"2018","unstructured":"Martin, S. et al. A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle. Genome Med. 10, 58 (2018).","journal-title":"Genome Med."},{"key":"8135_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-physiol-021014-071649","volume":"77","author":"H Xu","year":"2015","unstructured":"Xu, H. & Ren, D. Lysosomal physiology. Annu. Rev. Physiol. 77, 57\u201380 (2015).","journal-title":"Annu. Rev. Physiol."},{"key":"8135_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","volume":"1793","author":"T Braulke","year":"2009","unstructured":"Braulke, T. & Bonifacino, J. S. Sorting of lysosomal proteins. Biochim. Biophys. Acta 1793, 605\u2013614 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"8135_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.bi.55.070186.001123","volume":"55","author":"K von Figura","year":"1986","unstructured":"von Figura, K. & Hasilik, A. Lysosomal enzymes and their receptors. Annu. Rev. Biochem. 55, 167\u2013193 (1986).","journal-title":"Annu. Rev. Biochem."},{"key":"8135_CR23","doi-asserted-by":"publisher","first-page":"11761","DOI":"10.1074\/jbc.M513717200","volume":"281","author":"M Kudo","year":"2006","unstructured":"Kudo, M. & Canfield, W. M. Structural requirements for efficient processing and activation of recombinant human UDP-N-acetylglucosamine:lysosomal-enzyme-N-acetylglucosamine-1-phosphotransferase. J. Biol. Chem. 281, 11761\u201311768 (2006).","journal-title":"J. Biol. Chem."},{"key":"8135_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.1205677","volume":"333","author":"K Marschner","year":"2011","unstructured":"Marschner, K., Kollmann, K., Schweizer, M., Braulke, T. & Pohl, S. A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism. Science 333, 87\u201390 (2011).","journal-title":"Science"},{"key":"8135_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nm1305","volume":"11","author":"S Tiede","year":"2005","unstructured":"Tiede, S. et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha\/beta GlcNAc-1-phosphotransferase. Nat. Med. 11, 1109\u20131112 (2005).","journal-title":"Nat. Med."},{"key":"8135_CR26","unstructured":"Leroy, J. G., Cathey, S. & Friez, M. J. in GeneReviews [Internet] (eds Adam, M. P., et al.) (University of Washington, Seattle, 2008)."},{"key":"8135_CR27","unstructured":"Leroy, J. G., Cathey, S. S. & Friez, M. J. in GeneReviews [Internet] (eds Adam, M. P., et al.) (University of Washington, Seattle, 2008)."},{"key":"8135_CR28","unstructured":"Raas-Rothschild, A. & Spiegel, R. in GeneReviews [Internet] (eds Adam, M. P., et al.) (University of Washington, Seattle, 2010)."},{"key":"8135_CR29","first-page":"pii: e00939","volume":"8","author":"DL Lin","year":"2017","unstructured":"Lin, D. L. et al. Dengue virus hijacks a noncanonical oxidoreductase function of a cellular oligosaccharyltransferase complex. mBio 8, pii: e00939\u201317 (2017).","journal-title":"mBio"},{"key":"8135_CR30","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1073\/pnas.1013800108","volume":"108","author":"Y Rong","year":"2011","unstructured":"Rong, Y. et al. Spinster is required for autophagic lysosome reformation and mTOR reactivation following starvation. Proc. Natl Acad. Sci. USA 108, 7826\u20137831 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8135_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/j.1460-2075.1995.tb07042.x","volume":"14","author":"RD Palmiter","year":"1995","unstructured":"Palmiter, R. D. & Findley, S. D. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14, 639\u2013649 (1995).","journal-title":"EMBO J."},{"key":"8135_CR32","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1073\/pnas.1320629111","volume":"111","author":"SD Pirooz","year":"2014","unstructured":"Pirooz, S. D. et al. UVRAG is required for virus entry through combinatorial interaction with the class C-Vps complex and SNAREs. Proc. Natl Acad. Sci. USA 111, 2716\u20132721 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8135_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2016.10.007","volume":"136","author":"SR Welch","year":"2016","unstructured":"Welch, S. R. et al. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems. Antivir. Res. 136, 9\u201318 (2016).","journal-title":"Antivir. Res."},{"key":"8135_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/500849","volume":"78","author":"M Kudo","year":"2006","unstructured":"Kudo, M., Brem, M. S. & Canfield, W. M. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha \/ beta -subunits precursor gene. Am. J. Hum. Genet. 78, 451\u2013463 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"8135_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/hmg\/ddg025","volume":"12","author":"TS Blom","year":"2003","unstructured":"Blom, T. S. et al. Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease. Hum. Mol. Genet. 12, 257\u2013272 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"8135_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/jpet.108.139626","volume":"326","author":"JL Hawkins","year":"2008","unstructured":"Hawkins, J. L. et al. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J. Pharmacol. Exp. Ther. 326, 801\u2013808 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"8135_CR37","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1128\/AAC.02393-14","volume":"58","author":"M Flint","year":"2014","unstructured":"Flint, M. et al. Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses. Antimicrob. Agents Chemother. 58, 3206\u20133216 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8135_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2018.10.013","volume":"160","author":"DF Smee","year":"2018","unstructured":"Smee, D. F., Jung, K. H., Westover, J. & Gowen, B. B. 2\u2019-Fluoro-2\u2019-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models. Antivir. Res. 160, 48\u201354 (2018).","journal-title":"Antivir. Res."},{"key":"8135_CR39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tim.2011.07.003","volume":"19","author":"CC Friedel","year":"2011","unstructured":"Friedel, C. C. & Haas, J. Virus-host interactomes and global models of virus-infected cells. Trends Microbiol. 19, 501\u2013508 (2011).","journal-title":"Trends Microbiol."},{"key":"8135_CR40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","volume":"18","author":"S Tripathi","year":"2015","unstructured":"Tripathi, S. et al. Meta- and orthogonal integration of influenza \u201cOMICs\u201d data defines a role for UBR4 in virus budding. Cell. Host Microbe 18, 723\u2013735 (2015).","journal-title":"Cell. Host Microbe"},{"key":"8135_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/viro.1999.9915","volume":"262","author":"P Calain","year":"1999","unstructured":"Calain, P., Monroe, M. C. & Nichol, S. T. Ebola virus defective interfering particles and persistent infection. Virology 262, 114\u2013128 (1999).","journal-title":"Virology"},{"key":"8135_CR42","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/JVI.06346-11","volume":"86","author":"J Misasi","year":"2012","unstructured":"Misasi, J. et al. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J. Virol. 86, 3284\u20133292 (2012).","journal-title":"J. Virol."},{"key":"8135_CR43","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1128\/JVI.01170-07","volume":"81","author":"RL Kaletsky","year":"2007","unstructured":"Kaletsky, R. L., Simmons, G. & Bates, P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J. Virol. 81, 13378\u201313384 (2007).","journal-title":"J. Virol."},{"key":"8135_CR44","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","volume":"80","author":"K Schornberg","year":"2006","unstructured":"Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174\u20134178 (2006).","journal-title":"J. Virol."},{"key":"8135_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/JVI.01832-09","volume":"84","author":"AC Wong","year":"2010","unstructured":"Wong, A. C., Sandesara, R. G., Mulherkar, N., Whelan, S. P. & Chandran, K. A forward genetic strategy reveals destabilizing mutations in the Ebola virus glycoprotein that alter its protease dependence during cell entry. J. Virol. 84, 163\u2013175 (2010).","journal-title":"J. Virol."},{"key":"8135_CR46","doi-asserted-by":"publisher","first-page":"e1923","DOI":"10.1371\/journal.pntd.0001923","volume":"6","author":"A Marzi","year":"2012","unstructured":"Marzi, A., Reinheckel, T. & Feldmann, H. Cathepsin B & L are not required for ebola virus replication. PLoS Negl. Trop. Dis. 6, e1923 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"8135_CR47","doi-asserted-by":"publisher","first-page":"29899","DOI":"10.1074\/jbc.M504598200","volume":"280","author":"S Diederich","year":"2005","unstructured":"Diederich, S., Moll, M., Klenk, H. D. & Maisner, A. The nipah virus fusion protein is cleaved within the endosomal compartment. J. Biol. Chem. 280, 29899\u201329903 (2005).","journal-title":"J. Biol. Chem."},{"key":"8135_CR48","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1128\/JVI.06628-11","volume":"86","author":"S Diederich","year":"2012","unstructured":"Diederich, S. et al. Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. J. Virol. 86, 3736\u20133745 (2012).","journal-title":"J. Virol."},{"key":"8135_CR49","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1074\/jbc.M508381200","volume":"281","author":"IC Huang","year":"2006","unstructured":"Huang, I. C. et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281, 3198\u20133203 (2006).","journal-title":"J. Biol. Chem."},{"key":"8135_CR50","doi-asserted-by":"publisher","first-page":"24609","DOI":"10.1074\/jbc.M201107200","volume":"277","author":"DH Ebert","year":"2002","unstructured":"Ebert, D. H., Deussing, J., Peters, C., Dermody, T. S. & Cathepsin, L. and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277, 24609\u201324617 (2002).","journal-title":"J. Biol. Chem."},{"key":"8135_CR51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.15.1.821","volume":"15","author":"C Watts","year":"1997","unstructured":"Watts, C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821\u2013850 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"8135_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.cb.11.110195.001411","volume":"11","author":"PR Wolf","year":"1995","unstructured":"Wolf, P. R. & Ploegh, H. L. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell. Dev. Biol. 11, 267\u2013306 (1995).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"8135_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.0105-2896.2005.00310.x","volume":"207","author":"LC Hsing","year":"2005","unstructured":"Hsing, L. C. & Rudensky, A. Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229\u2013241 (2005).","journal-title":"Immunol. Rev."},{"key":"8135_CR54","doi-asserted-by":"publisher","first-page":"pii: e00660","DOI":"10.1128\/mBio.00660-18","volume":"9","author":"P Shrivastava-Ranjan","year":"2018","unstructured":"Shrivastava-Ranjan, P. et al. Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio 9, pii: e00660\u201318 (2018).","journal-title":"mBio"},{"key":"8135_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.virol.2011.11.008","volume":"423","author":"A Pasquato","year":"2012","unstructured":"Pasquato, A. et al. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1\/site-1 protease inhibitor PF-429242. Virology 423, 14\u201322 (2012).","journal-title":"Virology"},{"key":"8135_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1128\/JVI.02019-10","volume":"85","author":"S Urata","year":"2011","unstructured":"Urata, S. et al. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J. Virol. 85, 795\u2013803 (2011).","journal-title":"J. Virol."},{"key":"8135_CR57","doi-asserted-by":"publisher","first-page":"e00801","DOI":"10.1128\/mBio.00801-15","volume":"6","author":"LM Kleinfelter","year":"2015","unstructured":"Kleinfelter, L. M. et al. Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion. mBio 6, e00801 (2015).","journal-title":"mBio"},{"key":"8135_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2015.03.010","volume":"482","author":"S Shimada","year":"2015","unstructured":"Shimada, S., Posadas-Herrera, G., Aoki, K., Morita, K. & Hayasaka, D. Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection. Virology 482, 19\u201327 (2015).","journal-title":"Virology"},{"key":"8135_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.virol.2015.06.013","volume":"484","author":"CG Albarino","year":"2015","unstructured":"Albari\u00f1o, C. G., Wiggleton Guerrero, L., Lo, M. K., Nichol, S. T. & Towner, J. S. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein. Virology 484, 259\u2013264 (2015).","journal-title":"Virology"},{"key":"8135_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2014.03.011","volume":"106","author":"MK Lo","year":"2014","unstructured":"Lo, M. K., Nichol, S. T. & Spiropoulou, C. F. Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening. Antivir. Res. 106, 53\u201360 (2014).","journal-title":"Antivir. Res."},{"key":"8135_CR61","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/JVI.02501-07","volume":"82","author":"BH Bird","year":"2008","unstructured":"Bird, B. H. et al. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J. Virol. 82, 2681\u20132691 (2008).","journal-title":"J. Virol."},{"key":"8135_CR62","doi-asserted-by":"publisher","first-page":"e0201827","DOI":"10.1371\/journal.pone.0201827","volume":"13","author":"CG Albarino","year":"2018","unstructured":"Albari\u00f1o, C. G., Wiggleton Guerrero, L., Chakrabarti, A. K. & Nichol, S. T. Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses. PLoS One 13, e0201827 (2018).","journal-title":"PLoS One"},{"key":"8135_CR63","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"8135_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"8135_CR65","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1074\/jbc.M112.407676","volume":"288","author":"M Franke","year":"2013","unstructured":"Franke, M., Braulke, T. & Storch, S. Transport of the GlcNAc-1-phosphotransferase alpha\/beta-subunit precursor protein to the Golgi apparatus requires a combinatorial sorting motif. J. Biol. Chem. 288, 1238\u20131249 (2013).","journal-title":"J. Biol. Chem."},{"key":"8135_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","volume":"120","author":"EL Mohr","year":"2015","unstructured":"Mohr, E. L. et al. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antivir. Res. 120, 40\u201347 (2015).","journal-title":"Antivir. Res."},{"key":"8135_CR67","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1006\/viro.1995.1016","volume":"206","author":"RI Connor","year":"1995","unstructured":"Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935\u2013944 (1995).","journal-title":"Virology"},{"key":"8135_CR68","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/jvi.69.11.6705-6711.1995","volume":"69","author":"J He","year":"1995","unstructured":"He, J. et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705\u20136711 (1995).","journal-title":"J. Virol."},{"key":"8135_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2015.10.010","volume":"125","author":"LK McMullan","year":"2016","unstructured":"McMullan, L. K. et al. The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. Antivir. Res. 125, 71\u201378 (2016).","journal-title":"Antivir. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08135-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:10:35Z","timestamp":1671217835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-08135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8135"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-08135-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"19 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}